Skip to content

Author

N. Narainswami

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Comparative effectiveness and safety of adjunctive methotrexate in rhegmatogenous retinal detachment complicated by or at high risk for proliferative vitreoretinopathy: a systematic review and meta-analysis

Adjunctive MTX was associated with reduced postoperative PVR but not with improved final retinal reattachment, and the primary analysis suggested modestly better postoperative BCVA, but these findings are hypothesis-generating rather than practice-changing.

Renata Ramos Stropp, Tiago Nelson de Oliveira Rassi, Lúcio Roberto Cançado Castellano et al. · 0 citations
Review Sep 2026

Macular Edema and Intraocular Pressure Outcomes Following Periocular versus Topical Corticosteroids After Phacoemulsification: A Systematic Review and Meta-Analysis.

TOPIC Postoperative inflammation after phacoemulsification is routinely managed with topical corticosteroids, while periocular administration may provide a sustained anti-inflammatory effect. CLINICAL RELEVANCE Pseudophakic cystoid macular edema (PCME) remains a leading cause of suboptimal visual recovery after catar...

P. Sperotto, Nuno Rodrigues Alves, C. Valentim et al. · 0 citations
Review Open access Aug 2026

Functional Outcomes and Ocular Safety of Subretinal AAV-RPGR Gene Therapy for RPGR-Associated X-Linked Retinitis Pigmentosa: A Systematic Review and Meta-Analysis

Background/Objectives: We aimed to provide an updated synthesis of the efficacy and ocular safety of subretinal adeno-associated viral (AAV) RPGR gene therapy for retinitis pigmentosa GTPase regulator (RPGR)-associated X-linked retinitis pigmentosa (RPGR-XLRP) and to assess the certainty of the available evidence. Meth...

C. R. Montes-de-Oca-Saucedo, José Antonio Garza-Cruz, Bruno Briceño-Villardaga et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.